BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin. 2005;21:563-587. [PMID: 15992673 DOI: 10.1016/j.ccc.2005.03.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Saja MF, Abdo AA, Sanai FM, Shaikh SA, Gader AGMA. The coagulopathy of liver disease: does vitamin K help? Blood Coagulation & Fibrinolysis 2013;24:10-7. [DOI: 10.1097/mbc.0b013e32835975ed] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
2 Lateef A, Ojo SA, Elegbede JA, Akinola PO, Akanni EO. Nanomedical Applications of Nanoparticles for Blood Coagulation Disorders. In: Dasgupta N, Ranjan S, Lichtfouse E, editors. Environmental Nanotechnology. Cham: Springer International Publishing; 2018. pp. 243-77. [DOI: 10.1007/978-3-319-76090-2_8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 8.7] [Reference Citation Analysis]
3 Ng VL. Liver disease, coagulation testing, and hemostasis. Clin Lab Med. 2009;29:265-282. [PMID: 19665678 DOI: 10.1016/j.cll.2009.05.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
4 Kanikarla Marie P, Fowlkes NW, Afshar-Kharghan V, Martch SL, Sorokin A, Shen JP, Morris VK, Dasari A, You N, Sood AK, Overman MJ, Kopetz S, Menter DG. The Provocative Roles of Platelets in Liver Disease and Cancer. Front Oncol 2021;11:643815. [PMID: 34367949 DOI: 10.3389/fonc.2021.643815] [Reference Citation Analysis]
5 Radmand R, Schilsky M, Jakab S, Khalaf M, Falace DA. Pre-liver transplant protocols in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:426-30. [PMID: 23522643 DOI: 10.1016/j.oooo.2012.12.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Yates SG, Gavva C, Agrawal D, Sarode R. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?: TRANSFUSION IN CIRRHOSIS. Transfusion 2016;56:791-8. [DOI: 10.1111/trf.13495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
7 Pereira D, Liotta E, Mahmoud AA. The Use of Kcentra ® in the Reversal of Coagulopathy of Chronic Liver Disease. Journal of Pharmacy Practice 2018;31:120-5. [DOI: 10.1177/0897190017696952] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Stotts MJ, Davis JPE, Shah NL. Coagulation testing and management in liver disease patients. Curr Opin Gastroenterol 2020;36:169-76. [PMID: 32141899 DOI: 10.1097/MOG.0000000000000635] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 10.7] [Reference Citation Analysis]
10 Oh MS, Sung JM, Yeon HJ, Cho HJ, Ko JS, Kim GS, Lim H. Living-donor liver transplantation following cardiopulmonary bypass: A case report. Medicine (Baltimore) 2019;98:e17230. [PMID: 31567986 DOI: 10.1097/MD.0000000000017230] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Adam EH, Fischer D. Plasma Transfusion Practice in Adult Surgical Patients: Systematic Review of the Literature. Transfus Med Hemother 2020;47:347-59. [PMID: 33173453 DOI: 10.1159/000511271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Ko S, Chisuwa H, Matsumoto M, Fujimura Y, Okano E, Nakajima Y. Relevance of ADAMTS13 to liver transplantation and surgery. World J Hepatol 2015; 7(13): 1772-1781 [PMID: 26167250 DOI: 10.4254/wjh.v7.i13.1772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
13 Harrison MF. The Misunderstood Coagulopathy of Liver Disease: A Review for the Acute Setting. West J Emerg Med. 2018;19:863-871. [PMID: 30202500 DOI: 10.5811/westjem.2018.7.37893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
14 Akinwande KS, Olateru-Olagbegi O, Okwor CJ, Uche CZ, Eni BB, Edem VF. Prolonged blood coagulation time among occupationally exposed automobile technicians in Abeokuta, Nigeria. Toxicol Ind Health 2021;37:528-34. [PMID: 34388958 DOI: 10.1177/07482337211030425] [Reference Citation Analysis]
15 Ma Y, Chen E, Lu J, Tan M, Tang H. Hemoperitoneum in cirrhotic patients without abdominal trauma or tumor. Hepatobiliary & Pancreatic Diseases International 2011;10:644-8. [DOI: 10.1016/s1499-3872(11)60109-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
16 Chen JY, Chen WN, Liu LL, Lin WS, Jiao BY, Wu YL, Lin JY, Lin X. Hepatitis B spliced protein (HBSP) generated by a spliced hepatitis B virus RNA participates in abnormality of fibrin formation and functions by binding to fibrinogen γ chain. J Med Virol. 2010;82:2019-2026. [PMID: 20981788 DOI: 10.1002/jmv.21918] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
17 Klitgaard T, Nielsen TG. Overview of the human pharmacokinetics of recombinant activated factor VII. Br J Clin Pharmacol 2008;65:3-11. [PMID: 17961193 DOI: 10.1111/j.1365-2125.2007.03030.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
18 Zacharia GS, Kandiyil S, Thomas V. Pseudo-Ludwig's Phenomenon: A Rare Clinical Manifestation in Liver Cirrhosis. ACG Case Rep J 2014;2:53-4. [PMID: 26157906 DOI: 10.14309/crj.2014.83] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kim SY, Kim JE, Kim YJ, Han KS, Kim HK. Prominent protein Z-induced thrombin inhibition in cirrhosis: a new functional assay for hypercoagulability assessment. J Gastroenterol Hepatol 2015;30:784-93. [PMID: 25303721 DOI: 10.1111/jgh.12800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 刘鹏亮, 孙杰生, 王炳元, 秦永军. 肝硬化患者Child-Pugh分级与血小板生成素的关系. 世界华人消化杂志 2010; 18(4): 392-396 [DOI: 10.11569/wcjd.v18.i4.392] [Reference Citation Analysis]
21 Pillarisetti J, Patel P, Duthuluru S, Roberts J, Chen W, Genton R, Wiley M, Candipan R, Tadros P, Gupta K. Cardiac catheterization in patients with end-stage liver disease: Safety and outcomes. Cathet Cardiovasc Intervent 2011;77:45-8. [DOI: 10.1002/ccd.22591] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
22 Sucker C, Scharf RE, Zotz RB. Use of Recombinant Factor VIIa in Inherited and Acquired von Willebrand Disease. Clin Appl Thromb Hemost 2009;15:27-31. [DOI: 10.1177/1076029607310920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
23 Nevah MI, Fallon MB. Hepatic Encephalopathy, Hepatorenal Syndrome, Hepatopulmonary Syndrome, and Systemic Complications of Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1543-1555.e6. [DOI: 10.1016/b978-1-4160-6189-2.00092-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Lakhoo J, Bui JT, Zivin SP, Lokken RP, Minocha J, Ray CE, Gaba RC. Root Cause Analysis of Rebleeding Events following Transjugular Intrahepatic Portosystemic Shunt Creation for Variceal Hemorrhage. Journal of Vascular and Interventional Radiology 2015;26:1444-53. [DOI: 10.1016/j.jvir.2015.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
25 Karakoc D, Hamaloglu E, Ozdemir A, Dogrul A, Ozenc A. The effect of hepatectomy on coagulation: an evaluation by thromboelastography. Eur J Gastroenterol Hepatol. 2010;22:43-48. [PMID: 19773665 DOI: 10.1097/meg.0b013e32832f5bd1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Ferro D, Celestini A, Violi F. Hyperfibrinolysis in liver disease. Clin Liver Dis 2009;13:21-31. [PMID: 19150306 DOI: 10.1016/j.cld.2008.09.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
27 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol. 2010;91:20-29. [PMID: 20054668 DOI: 10.1007/s12185-009-0481-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
28 Dasher K, Trotter JF. Intensive Care Unit Management of Liver-Related Coagulation Disorders. Critical Care Clinics 2012;28:389-98. [DOI: 10.1016/j.ccc.2012.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Raffa S, Reverter JC, Seijo S, Tassies D, Abraldes JG, Bosch J, García–pagán JC. Hypercoagulability in Patients With Chronic Noncirrhotic Portal Vein Thrombosis. Clinical Gastroenterology and Hepatology 2012;10:72-8. [DOI: 10.1016/j.cgh.2011.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
30 Blonski W, Siropaides T, Reddy KR. Coagulopathy in liver disease. Curr Treat Options Gastroenterol 2007;10:464-73. [PMID: 18221607 DOI: 10.1007/s11938-007-0046-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
31 Anthony Lizarraga W, Dalia S, Reinert SE, Schiffman FJ. Venous thrombosis in patients with chronic liver disease. Blood Coagul Fibrinolysis. 2010;21:431-435. [PMID: 20595823 DOI: 10.1097/mbc.0b013e328337b3ba] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
32 Lakhoo J, Gaba RC. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis. Diagn Interv Imaging. 2016;97:1085-1093. [PMID: 27481577 DOI: 10.1016/j.diii.2016.07.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
33 Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011;113:1003-12. [PMID: 21918164 DOI: 10.1213/ANE.0b013e31822e183f] [Cited by in Crossref: 131] [Cited by in F6Publishing: 35] [Article Influence: 13.1] [Reference Citation Analysis]
34 Nguyen G, Lejeune M, Crichi B, Frere C. Hemostasis testing in patients with liver dysfunction: Advantages and caveats. World J Gastroenterol 2021; 27(42): 7285-7298 [DOI: 10.3748/wjg.v27.i42.7285] [Reference Citation Analysis]
35 Manyilizu WB, Mdegela RH, Kazwala R, Nonga H, Muller M, Lie E, Skjerve E, Lyche JL. Association of Long-Term Pesticide Exposure and Biologic Parameters in Female Farm Workers in Tanzania: A Cross Sectional Study. Toxics 2016;4:E25. [PMID: 29051428 DOI: 10.3390/toxics4040025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
36 An J, Shim JH, Kim SO, Lee D, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study. Circulation. 2014;130:1353-1362. [PMID: 25095888 DOI: 10.1161/circulationaha.114.009278] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 7.1] [Reference Citation Analysis]
37 Lin YT, Cheng YK, Lin CL, Wang IK. Increased risk of subdural hematoma in patients with liver cirrhosis. QJM 2017;110:815-20. [PMID: 29025006 DOI: 10.1093/qjmed/hcx167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 White PJ. Patient Factors That Influence Warfarin Dose Response. Journal of Pharmacy Practice 2010;23:194-204. [DOI: 10.1177/0897190010362177] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
39 Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39-50. [PMID: 27186144 DOI: 10.2147/hmer.s74612] [Cited by in Crossref: 18] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
40 Tripisciano C, Leistner A, Linsberger I, Leistner A, Falkenhagen D, Weber V. Effect of anticoagulation with citrate versus heparin on the adsorption of coagulation factors to blood purification resins with different charge. Biomacromolecules 2012;13:484-8. [PMID: 22229537 DOI: 10.1021/bm201529z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
41 Groose MK, Aldred BN, Mezrich JD, Hammel LL. Risk Factors for Intracardiac Thrombus During Liver Transplantation. Liver Transpl 2019;25:1682-9. [DOI: 10.1002/lt.25498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
42 Peck-Radosavljevic M. Review article: coagulation disorders in chronic liver disease. Aliment Pharmacol Ther 2007;26 Suppl 1:21-8. [PMID: 17958516 DOI: 10.1111/j.1365-2036.2007.03509.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
43 Kleinegris MC, Bos MH, Roest M, Henskens Y, Ten Cate-Hoek A, Van Deursen C, Spronk HM, Reitsma PH, De Groot PG, Ten Cate H. Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity. J Thromb Haemost. 2014;12:1647-1657. [PMID: 25142532 DOI: 10.1111/jth.12706] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
44 Saray A, Mesihović R, Vukobrat-Bijedić Z, Gornjaković S, Vanis N, Mehmedović A, Papović V, Glavaš S. Impact of sustained virus elimination on natural anticoagulant activity in patients with chronic viral hepatitis C. Bosn J Basic Med Sci 2013;13:84-8. [PMID: 23725503 DOI: 10.17305/bjbms.2013.2370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Hackner SG, Rousseau A. Bleeding Disorders. Small Animal Critical Care Medicine. Elsevier; 2015. pp. 554-67. [DOI: 10.1016/b978-1-4557-0306-7.00105-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
46 Krcmery J, Gupta R, Sadleir RW, Ahrens MJ, Misener S, Kamide C, Fitchev P, Losordo DW, Crawford SE, Simon HG. Loss of the cytoskeletal protein Pdlim7 predisposes mice to heart defects and hemostatic dysfunction. PLoS One 2013;8:e80809. [PMID: 24278323 DOI: 10.1371/journal.pone.0080809] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]